Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae (Q35648010)

9 August 2017

Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae (English)

1 reference

9 August 2017

Mycobacterium chelonae

1 reference

inferred from title

Mycobacterium fortuitum

object named as

Mycobacterium fortuitum

1 reference

4

Thornsberry C

1 reference

9 August 2017

Swenson JM

1

1 reference

9 August 2017

Wallace RJ Jr

series ordinal

2

1 reference

9 August 2017

Silcox VA

series ordinal

3

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 December 1985

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

1 reference

9 August 2017

28

1 reference

9 August 2017

6

1 reference

9 August 2017

807-811

1 reference

In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180333

Identification of clinically significant Mycobacterium fortuitum complex isolates

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180333

In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180333

Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180333

Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180333

In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180333

Spectrum of Disease Due to Rapidly Growing Mycobacteria

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180333

Identification of Mycobacterium fortuitum and Mycobacterium chelonei.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180333

Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180333

Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180333

In Vitro Susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to Amikacin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180333

Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180333

Antimicrobial Susceptibility Testing of Mycobacterium fortuitum Complex

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180333

Clinical Usefulness of Amikacin and Doxycycline in the Treatment of Infection Due to Mycobacterium fortuitum and Mycobacterium chelonei

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180333

Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum

25 September 2018

1 reference

12 December 2020

Sulfonamide Activity Against Mycobacterium fortuitum and Mycobacterium chelonei

1 reference

12 December 2020

In vitro susceptibility of mycobacterium fortuitum and mycobacterium chelonei to cefoxitin

1 reference

12 December 2020

In vitro susceptibility of Mycobacterium fortuitum and M. chelonei to sisomicin, gentamicin and tobramycin

1 reference

12 December 2020

Problems in diagnosis and therapy of Mycobacterium fortuitum infections

1 reference

12 December 2020

In vitro susceptibility of mycobacteria to rifampin

1 reference

12 December 2020

Activity of gentamicin against mycobacteria in vitro and against Mycobacterium tuberculosis in mice

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.28.6.807

1 reference

9 August 2017

1 reference

9 August 2017

1 reference